To translate data from cellular models into HCC patients, we studied transcript levels of PRAME in publicly available liver cancer datasets focusing on its expression in normal tissue versus HCC, as well as PRAME expression in the context of histological grade and invasive phenotype. This evidence concerns the gene PRAME and hepatocellular carcinoma.